RxDoctor Payments Data

Ximena Sanchez-Samper

Psychiatry · Boston, MANPI 1750363032

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $218,455 of the $257,585 with a category attached, or 84.8%. 4 manufacturers reported payments, led by Braeburn Inc. at 50.5% of the total. 2025 is the largest year on record at $113,153, 5.5 times the $20,698 reported in 2019. Among psychiatry clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$257,585in general payments, 2019–2025

Across 320 payments — averaging $804.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Braeburn Inc.$130K
  • Alkermes, Inc.$125K
  • Alnylam Pharmaceuticals Inc.$3K
  • Indivior Inc.$54

What the payments were for

  • Consulting fees$2,5601%
  • Speaking & faculty fees$218,45585%
  • Travel & lodging$26,37610%
  • Food & beverage$10,1744%
  • Education$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Braeburn Inc.195$130,096
Alkermes, Inc.122$124,684
Alnylam Pharmaceuticals Inc.1$2,750
Indivior Inc.2$54

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$257,585 in reported general payments places this provider in the 95th percentile of 1,431 psychiatry providers in Massachusetts.

See all psychiatry providers in Massachusetts

Other psychiatry in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →